11 U.S. lawmakers have disclosed 21 Edwards Lifesciences Corporation trades under the STOCK Act — 12 buys and 9 sells between 2016 and 2026. Congress has been net buyers of EW, and their disclosed buys are up 27.1% versus the latest close.
*Notional-weighted price return on lawmakers' disclosed buys of EW, marked to the latest close — per-share (share counts aren't disclosed).
Lawmakers ranked by notional-weighted return on their disclosed EW buys (last ~3y), marked to the latest close.
| Date | Member | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2026-03-27 | Alan Armstrong | BUY | $1K–$15K | $79.34 | $92.56 2026-08-13 | +16.7% |
| 2025-11-19 | Josh Gottheimer | SELL | $1K–$15K | $86.02 | $92.56 2026-08-13 | -7.6% exit |
| 2024-08-20 | Markwayne Mullin | SELL | $15K–$50K | $69.38 | $92.56 2026-08-13 | -5.2% rt |
| 2024-04-11 | Mike Kelly | SELL | $1K–$15K | $91.41 | $92.56 2026-08-13 | -1.3% exit |
| 2023-10-19 | Byron Donalds | BUY | $1K–$15K | $69.08 | $92.56 2026-08-13 | +34.0% |
| 2023-10-03 | Markwayne Mullin | BUY | $1K–$15K | $69.60 | $92.56 2026-08-13 | +33.0% |
| 2023-09-13 | Markwayne Mullin | BUY | $15K–$50K | $73.17 | $92.56 2026-08-13 | +26.5% |
| 2023-08-11 | Rohit Khanna | BUY | $1K–$15K | $79.41 | $92.56 2026-08-13 | +16.6% |
| 2023-06-21 | John Curtis | BUY | $1K–$15K | $91.09 | $92.56 2026-08-13 | +1.6% |
| 2023-04-26 | John Curtis | BUY | $1K–$15K | $87.41 | $92.56 2026-08-13 | +5.9% |
| 2023-04-03 | Thomas H Tuberville | SELL | $1K–$15K | $82.17 | $92.56 2026-08-13 | -12.6% exit |
| 2023-04-03 | Thomas H Tuberville | SELL | $1K–$15K | $82.17 | $92.56 2026-08-13 | -0.3% rt |
| 2021-09-16 | Katherine M. Clark | SELL | $1K–$15K | $120.69 | $92.56 2026-08-13 | +23.3% exit |
| 2021-06-03 | Byron Donalds | BUY | $1K–$15K | $94.34 | $92.56 2026-08-13 | -1.9% |
| 2021-05-05 | Byron Donalds | BUY | $1K–$15K | $91.77 | $92.56 2026-08-13 | +0.9% |
| 2021-03-29 | Thomas H Tuberville | BUY | $1K–$15K | $82.43 | $92.56 2026-08-13 | +12.3% |
| 2021-03-05 | Byron Donalds | BUY | $1K–$15K | $81.72 | $92.56 2026-08-13 | +13.3% |
| 2019-07-30 | Gilbert Cisneros | SELL | $1K–$15K | $72.29 | $92.56 2026-08-13 | -28.0% exit |
| 2017-11-01 | Lamar Smith | SELL | $1K–$15K | $33.94 | $92.56 2026-08-13 | -172.7% exit |
| 2017-06-12 | Lamar Smith | SELL | $1K–$15K | $38.13 | $92.56 2026-08-13 | +28.6% rt |
| 2016-12-12 | Lamar Smith | BUY | $1K–$15K | $29.64 | $92.56 2026-08-13 | +212.3% |
Return: buys marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (stock move after the sale, seller's perspective).
11 members of the U.S. House and Senate have disclosed Edwards Lifesciences Corporation transactions under the STOCK Act — 12 purchases and 9 sales. The full member-by-member breakdown, with dates and dollar ranges, is in the table above.
No member of Congress has disclosed a EW purchase in the last 90 days. STOCK Act filings lag the trade by up to 45 days, so newer buys may still be pending disclosure.
Notional-weighted, lawmakers' disclosed EW buys are up 27.1% versus the latest close of $92.56. Each trade's own return — and realized round-trips on matched sells — is in the Return column.
Yes. Under the 2012 STOCK Act, members of Congress may buy and sell individual stocks but must publicly disclose each transaction within 45 days. Bargo surfaces those filings so you can see who traded EW and how it performed.